Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong
Xtalks Life Science Podcast

Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong

2025-08-19
In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Rob Armstrong, PhD, CEO of Artax Biopharma, a company pioneering a novel class of oral small molecule drugs known as Nck modulators to treat autoimmune diseases. Unlike traditional therapies that suppress the immune system, Artax’s approach aims to restore immune balance by modulating T cell receptor signaling. Dr. Armstrong shares insights into the company’s recent clinical progress, including positive Phase IIa results in ...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free